PRPH Competitors & Alternatives
Compare ProPhase Labs Inc with similar stocks in the same industry
Diagnostics & Research
PRPH
Main Stock$0.36
Tradestie Score
56
Market Cap
$21.41M
Revenue Growth
-0.4%
Analyst Upside
+3705.8%
Top Competitors
40 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CDNA
CareDx, Inc.
|
$43.71
|
$798.40M | - | 45 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$16.55
|
$719.31M | - | 54 | Compare |
|
MYGN
Myriad Genetics Inc
|
$2.86
|
$719.23M | - | 55 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$28.00
|
$667.77M | - | 57 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$12.66
|
$612.76M | - | 48 | Compare |
|
ICCC
Immucell Corp
|
$11.21
|
$59.70M | - | 47 | Compare |
|
CPIX
Cumberland Pharmaceuticals Inc
|
$6.68
|
$46.68M | - | 55 | Compare |
|
NAII
Natural Alternatives International Inc.
|
$2.29
|
$17.91M | - | 46 | Compare |
|
XTLB
XTL Biopharmaceuticals Ltd. American Depositary Shares
|
$2.82
|
$10.14M | - | 51 | Compare |
|
SNOA
Sonoma Pharmaceuticals, Inc. Common Stock
|
$1.10
|
$6.37M | - | 44 | Compare |
More PRPH Analysis
Data updated: Aug 03, 2026 | Industry: Diagnostics & Research (SIC 2834)
40 stocks in this industry